298 related articles for article (PubMed ID: 9626660)
1. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
3. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
5. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
6. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
7. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
8. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
El Khissiin A; Journé F; Laïos I; Seo HS; Leclercq G
Steroids; 2000 Dec; 65(12):903-13. PubMed ID: 11077089
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
Oesterreich S; Zhang Q; Hopp T; Fuqua SA; Michaelis M; Zhao HH; Davie JR; Osborne CK; Lee AV
Mol Endocrinol; 2000 Mar; 14(3):369-81. PubMed ID: 10707955
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
[TBL] [Abstract][Full Text] [Related]
13. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
15. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
16. Estrogen stimulation of creatine kinase B specific activity in 3T3L1 adipocytes after their differentiation in culture: dependence on estrogen receptor.
Sömjen D; Tordjman K; Waisman A; Mor G; Amir-Zaltsman Y; Kohen F; Kaye AM
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):401-8. PubMed ID: 9449243
[TBL] [Abstract][Full Text] [Related]
17. Distribution plasticity of the human estrogen receptor alpha in live cells: distinct imaging of consecutively expressed receptors.
Pick H; Jankevics H; Vogel H
J Mol Biol; 2007 Dec; 374(5):1213-23. PubMed ID: 17991486
[TBL] [Abstract][Full Text] [Related]
18. Differential subcellular distribution and transcriptional activity of sigmaE3, sigmaE4, and sigmaE3-4 isoforms of the rat estrogen receptor-alpha.
Pasqualini C; Guivarc'h D; Barnier JV; Guibert B; Vincent JD; Vernier P
Mol Endocrinol; 2001 Jun; 15(6):894-908. PubMed ID: 11376109
[TBL] [Abstract][Full Text] [Related]
19. An estrogen receptor chimera senses ligands by nuclear translocation.
Martinez ED; Rayasam GV; Dull AB; Walker DA; Hager GL
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):307-21. PubMed ID: 16162406
[TBL] [Abstract][Full Text] [Related]
20. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
Ince BA; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
